Gemini says: In the framework of Alliance Theory, the Journal of the American Medical Association (JAMA) functions as the high-status gatekeeper for the American medical guild. While the New England Journal of Medicine often feels like a legacy aristocracy, JAMA is the political engine of the American Medical Association (AMA). Its primary role is to coordinate the “expert alliance” by turning complex data into the “gold standard” protocols that doctors use to maintain their social authority.
The “inside baseball” of JAMA reveals a publication that is deeply enmeshed in the struggle to keep its alliance unified in a fragmenting political landscape.
The Strategic Defensive Retraction
A defining moment in JAMA’s recent alliance history occurred in 2021, centered on a podcast and a tweet about structural racism. A deputy editor suggested that “taking racism out of the conversation” would help, arguing that no physician is truly racist because such behavior is illegal. From a Pinsofian perspective, this was a catastrophic failure of “tagging.” The editor used an old-school colorblind tag that had become toxic to the rising elite alliance in academia and public health.
The backlash was so intense that the Editor-in-Chief, Howard Bauchner, was forced to step down after a months-long investigation. The journal didn’t just delete the podcast; it engaged in a “purification ritual.” It hired new editors specifically tasked with health equity and launched a systematic review of all editorial processes. This wasn’t just about medicine; it was about JAMA signaling to its allies in the federal government and elite universities that it was still a loyal member of the modern progressive coalition.
The Pharma-Funding Alliance
JAMA operates as a “hybrid” prestige machine. It maintains an elite status through a sub-10% acceptance rate, but it is also a massive revenue generator for the AMA. Unlike journals that rely purely on subscriptions, JAMA is famous for its high-gloss pharmaceutical advertisements.
This creates a “triadic alliance” between the journal, the medical profession, and the pharmaceutical industry. The journal publishes the landmark clinical trials that justify new, expensive treatments. Pharma then buys advertising space in that same journal to market those treatments back to the doctors who read it. The “patchwork narrative” is that this is a seamless circle of innovation. A more cynical Alliance Theory view suggests it is a mutually beneficial status game where the journal provides the “moral and scientific cover” for a massive transfer of wealth from insurers and patients to the medical-industrial complex.
US-Centric Boundary Work
While The Lancet focuses on global health and Nature Medicine on basic science, JAMA’s core alliance is domestic. It specializes in “Practice-Changing Findings” for the American context. By publishing the specific guidelines for everything from blood pressure targets to opioid prescriptions, JAMA ensures that the American physician remains the “sole authorized dealer” of medical truth. This “boundary work” prevents other alliances—like holistic practitioners or data scientists—from encroaching on the medical guild’s high-status territory.
JAMA’s power is its ability to take a messy reality and distill it into a “consensus” that its members can use to justify their high status and high pay. When that consensus breaks, as it did in 2021, the journal must move quickly to “re-tag” itself or risk being replaced by a more politically savvy rival.
Stephen Turner views expertise not as a magical possession of truth but as a relational product. In his work, specifically The Social Theory of Practices and The Politics of Expertise, he argues that what we call shared practices or collective tacit knowledge is actually a myth. There is no central server where doctors download the JAMA way of thinking. Instead, individuals undergo separate, private learning processes. They only appear to share a practice because they respond to similar external pressures and feedback loops.
JAMA serves as the primary mechanism for this feedback. It provides the communicative substitutes that allow thousands of individual doctors to coordinate their behavior without ever actually sharing the same inner cognitive state.
The Myth of Shared Tacit Knowledge
Turner argues that tacit knowledge is inherently unshareable. Two doctors may read the same JAMA study on hypertension, but they process it through different neural pathways and career histories. JAMA solves this problem of epistemic individualism by providing what Turner calls authoritative closure. It translates messy, individualized clinical experience into a public, standardized language.
When JAMA publishes a guideline, it is not uncovering a pre-existing consensus. It is creating a functional substitute for it. It gives the profession a set of slogans and protocols that allow doctors to act in unison. This creates the illusion of a unified medical mind, which is the necessary foundation for professional authority in a liberal democracy.
Epistemic Inequality and the Guild
In Liberal Democracy 3.0, Turner discusses the crisis of epistemic inequality. Most citizens cannot judge the claims scientists make. JAMA exploits this gap to maintain the medical guild’s monopoly. By setting the standards for what counts as legitimate research, the journal performs boundary work that protects the doctor’s status from competitors like data scientists or alternative practitioners.
The journal functions as an instrument of delegation. In a complex society, the public delegates its judgment to experts. JAMA ensures that this delegation remains directed toward the American Medical Association. It provides the institutional means to aggregate knowledge and, more importantly, to legitimate it. This legitimation is not about being right in an absolute sense; it is about being defensible in a social and legal sense.
Failure of Tagging and Ritual Purification
The 2021 retraction and the subsequent resignation of the Editor-in-Chief illustrate Turner’s point about the fragility of these coordination mechanisms. The deputy editor used an old-school colorblind framework that no longer functioned as a successful communicative substitute for the rising elite alliance. It failed to coordinate the expectations of the relevant audience.
The resulting purification ritual—hiring health equity editors and launching systematic reviews—was an attempt to re-establish a reliable set of signals. According to Turner, when the tacit schemes of a group no longer align with the external political environment, the institution must provide new explicit rules. JAMA didn’t just change its mind; it updated its signaling software to ensure the medical alliance remained compatible with the broader administrative state.
Optimizing for Governability
Turner notes that expertise is essentially something delivered at the request of someone else who wants it. JAMA’s real clients are not just doctors, but also insurers, regulators, and lawyers. These clients need a world that is governable.
JAMA favors large observational studies and pragmatic trials because they produce the kind of knowledge that can be operationalized into law and policy. Speculative or mechanistic science is high-risk because it is hard to coordinate around. JAMA prefers the slow, elite-mediated change that Turner identifies as a hallmark of high-liability professions. The journal ensures that the American physician remains the authorized dealer of medical truth by locking in authority rather than exploring every epistemic possibility.
Stephen Turner famously critiques the idea of normativity as a mysterious, extra-physical force that compels people to follow rules. In his view, there are no “norms” floating in a collective social space. There are only individuals who have developed similar habits because they face similar social sanctions. When JAMA publishes an editorial with an explicit ethical framing, it is not actually appealing to a shared moral truth. It is creating a “normative” map that doctors must follow to avoid being socially or legally “out of bounds.”
JAMA uses these ethical editorials to provide what Turner calls the “good reasons” for professional behavior. Medicine is a high-stakes field where practitioners must constantly justify their power. By framing technical clinical decisions as moral obligations, JAMA helps the physician internalize a specific vocabulary of justification. If a doctor can point to a JAMA-sanctioned ethical stance, they are protected from the charge that they are merely acting out of self-interest or cold calculation. This turns a potentially messy political conflict into a matter of “professional virtue.”
The journal essentially manages the “risk of being wrong” by defining what it means to be “right” in a way that is institutionally usable. This creates a predictable environment for the administrative state. Insurers and regulators do not want to negotiate with thousands of individual moral consciences. They want a single, authoritative moral standard they can plug into their systems. JAMA’s editorials provide this standard by translating the diverse, tacit moral intuitions of individual doctors into a unified, explicit code.
This process reinforces the “buffered self” of the profession. By providing these ready-made ethical justifications, JAMA allows the individual doctor to act as a representative of a larger, virtuous whole. The “normativity” found in the journal’s pages is actually a coordination device. It ensures that when a doctor is challenged—whether in a malpractice suit or a public debate—they can speak with the “voice of the profession” rather than just their own.
Stephen Turner views “social facts” as a convenient fiction used by sociologists and experts to claim that a collective mind or a shared “we” exists. In reality, Turner argues there are only individuals with habits that happens to align because they are trained in the same way. JAMA functions as the primary training ground for these habits. It creates the “social fact” of medical consensus by excluding any data that does not come from its own sanctioned lineage.
Decentralized medical movements or citizen science represent a direct threat to this model because they bypass the “black box” of professional training. For an expert alliance like the AMA, knowledge is only valid if it is produced through a specific set of institutional habits—peer review, clinical trial hierarchies, and credentialed authorship. When a group of patients or independent “biohackers” aggregates data on a platform, they are creating a competing set of habits. Turner would point out that JAMA must remain hostile to these movements because its own authority depends on the claim that there is only one “correct” way to possess medical knowledge.
If JAMA acknowledges decentralized science, it admits that “medical truth” can exist outside its own guild. This would dissolve the “mysterious” quality of expertise that Turner describes. Expertise is a form of cognitive property; by framing citizen science as “anecdotal” or “dangerous,” JAMA performs the boundary work necessary to keep that property valuable. It ensures that the individual physician remains the only “authorized dealer” by delegating the power of truth-making to a central hub.
This hostility is also about the “risk of being wrong.” In Turner’s view, experts are essentially people who are paid to take the blame for others. A decentralized movement has no “center” to blame when things go wrong. JAMA, however, provides a clear, litigable trail of authority. It offers a standardized “habit” that a doctor can point to in court. Citizen science offers no such shield, which makes it “un-usable” for the administrative state and the legal system that JAMA serves.
Stephen Turner’s “death of the social” refers to the collapse of the idea that a unified “society” exists as a coherent object that can be managed by the state. As traditional social structures—like neighborhoods, churches, and stable labor markets—fragmented, the administrative state lost its primary “territory” of government. JAMA’s recent obsession with Social Determinants of Health (SDH) represents a desperate institutional land grab to re-colonize this lost territory under the banner of medical expertise.
By pathologizing social life—viewing housing, diet, and social networks as “medical” variables—JAMA is attempting to restore the link between expert knowledge and political power. If “the social” is dead as a political concept, it can be resurrected as a clinical one.
Recapturing the Territory of Government
In Turner’s framework, expertise thrives when it can “aggregate” messy reality into something the state can use. When JAMA publishes on SDH, it is not just observing that being poor is bad for your health; it is converting poverty into a technical metric. This makes “the social” legible again for administrative interventions. By framing systemic issues as medical ones, the journal ensures that the doctor remains at the center of the governance of life itself.
This recapture is a response to the “crisis of legitimation” that Turner identifies in The Politics of Expertise. As public trust in purely technical medicine wavered, the medical alliance needed a new moral frontier to justify its high status. SDH provides a “progressive” moral vocabulary that aligns the guild with the modern administrative state’s desire to regulate every aspect of human existence.
From “The Social” to “The Biological”
The death of the social forced a shift in how power is exercised. Turner notes that when you can no longer govern through “social” institutions, you govern through the individual’s habits and biology. JAMA’s focus on SDH translates social problems into individual risk profiles. This allows for a form of “biopolitics” where the expert doesn’t just treat a disease, but manages the patient’s entire life-world.
This translation is a crucial coordination device. It gives doctors a way to talk about politics without sounding like politicians. They are “just following the data” on health equity. According to Turner, this is how expert alliances survive—by expanding their jurisdiction into new domains whenever their old ones become contested or exhausted.
The Illusion of Shared Practice in Public Health
Turner would argue that there is no shared “practice” of health equity that all JAMA readers truly hold in common. Instead, JAMA provides the “communicative substitutes”—the slogans, the buzzwords, and the “best practice” protocols—that allow the medical class to act as if they share a unified vision.
The focus on SDH is a way to create a new “social fact” where none exists. It imposes a standardized “habit” of thought on the profession, ensuring that the medical alliance speaks with one voice to the state. This is not about the “truth” of social causes of disease; it is about the institutional utility of having a single, authoritative framework for managing a fragmented population.
Stephen Turner rejects the idea of collective intentionality. He does not believe that a community or a guild can have a “we-intention” or a shared mind. To Turner, what we call a “community” is just a collection of individuals who have developed similar habits because they are responding to the same signals. JAMA’s focus on “community health” often feels like a top-down administrative exercise because it is exactly that. It is an attempt to manufacture a “we” where one does not naturally exist.
The journal treats “the community” as a laboratory. It provides doctors with a set of instructions on how to interact with this abstract entity. These instructions are not based on the organic, messy, and unshareable tacit knowledge of the people living in those neighborhoods. Instead, they are based on standardized metrics that can be tracked and reported. This creates a feedback loop where the medical alliance talks to itself about the community, using the community’s data, without ever actually sharing a “practice” with the community.
This creates a significant gap. The people in the community have their own tacit ways of living and surviving that are invisible to the medical expert. Because these ways of living are not “legitimate” in the pages of JAMA, they are ignored or pathologized. Turner would argue that JAMA’s “community” is a simulation designed to make the population governable. The experts are not joining a community; they are administrative outsiders who use the language of “partnership” to justify their jurisdiction over social life.
The administrative state prefers this top-down approach because it is predictable. An organic social movement is chaotic and hard to control. A JAMA-sanctioned “community health initiative” is legible, fundable, and manageable. It replaces the “death of the social” with a clinical bureaucracy. The “collective” in community health is not a living group of people with shared intentions. It is a statistical aggregate that the medical guild manages to maintain its status as the primary intermediary between the individual and the state.
JAMA provides the “good reasons” for this intervention. It frames the expansion of medical authority as a moral necessity. This prevents the individual doctor from seeing the exercise as a form of power. By using the language of ethics and equity, the journal helps the expert internalize a habit of mind where their administrative work is seen as a virtuous service. Turner’s work suggests that this is the ultimate function of expertise: to provide the justifications that allow power to be exercised without appearing as power.
Stephen Turner distinguishes between “tradition”—which he views as a historical sequence of events and individual learning—and “practice,” which is the false claim that a mysterious, shared “soul” of an institution exists across time. JAMA is obsessed with its own legacy because it must maintain the illusion of a continuous, authoritative “practice” to justify its present-day power.
By constantly referencing its long history and “legacy” status, JAMA attempts to ground its current expertise in something more permanent than the shifting political winds of 2026. This creates what Turner calls a “pedigree.” The pedigree suggests that a JAMA paper today is part of the same unbroken chain of truth that began in 1883. In reality, the medical habits and political alliances of the 19th century have nothing in common with modern clinical trials. The “tradition” is actually a series of radical breaks and re-tagging exercises, but JAMA must present it as a stable, evolving “practice” to maintain public trust.
This obsession with history is a form of institutional self-defense. If JAMA is just a contemporary political engine for the AMA, its authority is open to challenge. But if it is the steward of a “great tradition” of American medicine, it becomes a sacred institution. Turner argues that we use the word “practice” to hide the fact that we are just individual actors who have been trained to respond to the same stimuli. JAMA’s “legacy” is the narrative glue that holds these individual doctors together. It gives them the “good reasons” to believe they belong to something larger than a professional guild.
The journal uses its archives to create a sense of inevitability. It frames its past mistakes as “steps in a journey” toward the current consensus. This ensures that the expert is never seen as a mere creature of the present. According to Turner, the “tradition” is a tool for managing the future. By controlling the history of medical truth, JAMA ensures it remains the only legitimate author of its next chapter.
Stephen Turner’s analysis of the replication crisis focuses not on the “truth” of the science, but on the fragility of the expert alliance. In The Politics of Expertise, he suggests that expertise is a fragile social contract. If the “knowledge” provided by experts fails to produce predictable results, the public’s delegation of authority is withdrawn.
JAMA treats the replication crisis as a technical problem to be solved with more rigorous “standards,” but Turner would argue it is actually a crisis of coordination. When landmark studies published in high-status journals cannot be replicated, the “communicative substitutes” that JAMA provides to the medical guild begin to break down. If the “gold standard” protocols do not work, doctors lose their “good reasons” for their high status and high pay.
Managing the Fragility of Expertise
To Turner, the primary job of a journal like JAMA during a replication crisis is “closure.” It must move quickly to decide which failures are “real” and which are merely “statistical noise.” This is not an epistemic process; it is a defensive one. If JAMA admits that a significant portion of its past “consensus” was wrong, it risks exposing the entire medical guild to a loss of public trust and increased legal liability.
The journal’s solution is to double down on what Turner calls “methodological fetishism.” By mandating ever-more complex statistical hurdles and “transparency” checklists, JAMA creates the illusion that the problem is being managed. This allows the alliance to claim that while individual studies may fail, the process of the guild remains infallible.
The Cost of Epistemic Humility
Turner notes that in high-stakes professions, epistemic humility is actually a liability. If a doctor tells a patient, “This study might not replicate,” they undermine their own authority. JAMA therefore filters the replication crisis through a lens of “progressive improvement.” It frames the failure to replicate as “science working as intended” rather than a fundamental breakdown of the expert-client relationship.
This prevents the “legal and political chaos” that would ensue if the administrative state could no longer rely on JAMA for authoritative closure. By gatekeeping which replications are “valid,” JAMA ensures that the transition from one medical “habit” to another remains slow and elite-mediated.
Protecting the Cognitive Property
The replication crisis threatens the “cognitive property” of the medical profession. If anyone with a computer can find flaws in a JAMA study, the barrier to entry for medical truth-making drops. Turner would argue that JAMA’s response—increasing the complexity and cost of peer review—is a way to re-privatize that property. It ensures that only those within the elite academic alliance have the resources to challenge the consensus.
In this light, JAMA’s caution is not just scientific; it is a form of “closure” that protects the guild from the “renegades” or “heterodox practitioners” who might use the replication crisis to challenge professional monopolies. The journal ensures that even when the science is messy, the authority remains unified.
Stephen Turner’s work on the technicization of politics describes a process where political conflicts—which involve irreconcilable interests and values—are laundered into technical or scientific problems. By framing issues like structural racism, gun violence, or climate change as “public health crises,” JAMA performs a vital service for the administrative state: it removes these topics from the arena of public debate and places them under the jurisdiction of experts.
Removing the “Political” from Politics
In Liberal Democracy 3.0, Turner argues that liberal democracy is increasingly replaced by an “expertocracy.” In this system, the “public health” label functions as a conversation-stopper. You cannot vote against a virus, and you cannot easily argue with a “clinical finding.” When JAMA redefines a social conflict as a health crisis, it effectively disenfranchises the lay public. The decision-making power shifts from voters and politicians to the “expert alliance” that JAMA coordinates.
This technicization is a response to the “crisis of legitimacy.” If the government tried to implement certain social policies through traditional legislation, it would face fierce opposition. However, if JAMA publishes a study “proving” that a social condition is a medical risk, the state can implement those same policies as “evidence-based health interventions.” This makes the exercise of power appear neutral and objective rather than partisan.
The Problem of Ill-Formed Problems
Turner points out that many of these “public health crises” are what he calls ill-formed problems. They are multidisciplinary issues with no single optimal solution. Gun violence, for example, involves sociology, law, ethics, and psychology. By claiming the lead, the medical profession—via JAMA—imposes its own “microscopic” specialized worldview on a macroscopic problem.
This process often ignores the “tacit” knowledge of the people actually living within these social contexts. JAMA’s findings are optimized for “governability”—they produce the kind of data that regulators can use to justify new rules. Turner would argue that this doesn’t actually solve the social problem; it simply expands the “medical-industrial complex” into new areas of life.
The Role of “Expert Failure”
The risk in this strategy is what Turner calls “expert failure.” When experts step outside their narrow domain of expertise to manage “the social,” they are much more likely to get things wrong. The 2021 JAMA structural racism controversy was a perfect example of this. The editors tried to manage a political “tagging” exercise and failed catastrophically because they were operating in a political landscape they didn’t fully understand.
According to Turner, when experts fail at politics, they don’t retreat. Instead, they double down on “purification rituals” and more complex administrative protocols. JAMA’s current obsession with “equity” and “social determinants” is an attempt to build a more robust political-technical hybrid that can survive the next expert failure. It is an effort to make the “medical alliance” a permanent, unassailable partner of the administrative state.
To understand the power dynamics at JAMA through Stephen Turner’s lens, we must look past the clinical titles and identify the individuals who function as the primary engineers of authoritative closure. These are the people who decide which “habits of mind” become the mandatory protocols for the American medical guild.
1. Kirsten Bibbins-Domingo, MD, PhD, MAS (Editor-in-Chief)
She is the undisputed sovereign of the JAMA Network. Following the 2021 “purification ritual” that saw her predecessor ousted, Bibbins-Domingo was installed to re-tag the journal for the modern era. Her background in epidemiology and her work with the U.S. Preventive Services Task Force make her an expert in the “technicization of politics.” She does not just oversee a journal; she oversees the transition of medical authority into the realm of population health and equity. Under her leadership, JAMA has moved aggressively to define “social determinants of health” as a technical medical domain.
2. James L. Madara, MD (CEO of the American Medical Association)
While he is not an editor, Madara is the architect of the journal’s institutional parentage. Because JAMA is the intellectual arm of the AMA guild, Madara represents the ” Pharma-Funding Alliance” and the guild’s interest in professional monopoly. He ensures that JAMA’s output remains institutionally usable for the AMA’s lobbying and regulatory goals. He holds the ultimate purse strings and ensures the journal remains a “hybrid prestige machine” that generates the revenue necessary for the guild’s political survival.
3. Gregory Curfman, MD (Executive Editor)
A veteran of the New England Journal of Medicine, Curfman is the “master of habits.” His role is to ensure the “methodological fetishism” that protects the journal from the replication crisis. He manages the day-to-day enforcement of peer-review standards, which Turner would describe as the policing of cognitive property. Curfman ensures that the papers published meet the rigorous, conservative criteria required to survive legal and political cross-examination.
4. Annette Flanagin, RN, MA (Executive Managing Editor)
Flanagin is the gatekeeper of the “communicative substitutes.” She has spent decades managing the editorial processes and the AMA Manual of Style. She ensures that the diverse, tacit intuitions of individual researchers are translated into the standardized, authoritative language that hospitals and insurers require. In Turner’s view, she is a key figure in creating the “illusion of shared practice” by maintaining a unified editorial voice across the entire JAMA Network.
5. The “Equity” Editors
This is a collective power block rather than a single individual. Following the 2021 crisis, JAMA hired a cadre of editors specifically tasked with health equity. Their power lies in their role as “moral gatekeepers.” They ensure that every technical decision is framed as a moral obligation, effectively aligning the medical alliance with the administrative state’s current ideological requirements. They are the primary agents of “re-tagging” the journal to ensure it remains a loyal member of the modern elite coalition.
These power players do not just manage a publication. They manage the boundary work that prevents other alliances—like decentralized citizen scientists—from encroaching on the medical guild’s high-status territory. They provide the “gold standard” protocols that allow thousands of individual doctors to act in unison, creating the “social fact” of a unified medical profession.
ChatGPT says: JAMA is the command-and-control journal of American clinical medicine. Not a pure science venue. Not a discovery engine. A standards-setting instrument for a very powerful professional alliance.
If Nature coordinates science and Science coordinates institutions, JAMA coordinates doctors.
JAMA exists to align the American physician class around shared definitions of best practice, risk, legitimacy, and professional virtue. Its core output is not truth but authoritative closure.
A JAMA paper tells hospitals, insurers, residency programs, medical boards, and malpractice lawyers that a position is safe to adopt.
That is enormous power.
Institutional parentage is everything. JAMA is published by the American Medical Association. That alone explains most of its behavior.
The AMA’s historical role is guild protection. Licensing. Scope control. Reimbursement norms. Professional authority. Public trust.
JAMA is the intellectual arm of that guild.
Alliance Theory translation. JAMA selects research that reinforces the legitimacy, coherence, and defensibility of physician-led medicine in the US system.
Clinical medicine is uniquely exposed to liability, regulation, and moral scrutiny. Doctors need shared justifications for decisions that involve uncertainty, tradeoffs, and harm.
JAMA supplies those justifications.
Once something appears in JAMA, it becomes defensible in court, in peer review, in credentialing disputes, and in hospital politics. That is why guideline committees treat JAMA as upstream authority.
The science does not have to be perfect. It has to be institutionally usable.
What JAMA rewards
JAMA disproportionately favors work that
• affects clinical decision-making at scale
• can be operationalized into guidelines
• aligns with payer and regulator expectations
• reinforces physician centrality over alternatives
• can survive legal and political cross-examination
This is why JAMA often prioritizes large observational studies, consensus statements, and pragmatic trials over mechanistic or speculative work.
It is optimizing for governability.
Peer review at JAMA is brutally conservative. The real question is not “Is this interesting” but “Would endorsing this expose the profession to risk.”
Risk here means
• malpractice exposure
• regulatory backlash
• congressional scrutiny
• loss of public trust
• erosion of physician authority
Alliance Theory predicts this. In high-liability professions, belief systems evolve to minimize blame.
JAMA’s caution is not timidity. It is institutional self-defense.
Unlike Nature or PNAS, JAMA often publishes editorials with explicit ethical framing. That is not mission drift.
Medicine is a moral profession in the public imagination. Physicians justify power by claiming ethical restraint and patient-first values.
JAMA reinforces that narrative. It frames technical decisions as moral obligations. This protects the alliance by aligning authority with virtue.
Clinicians who challenge dominant treatment paradigms often experience JAMA as hostile or dismissive. Alliance Theory explains why.
Paradigm challenges raise coordination costs. They force doctors to disagree publicly, which increases liability and erodes trust.
JAMA therefore prefers slow, elite-mediated change over disruptive correction. Even when dissenters are right, they are costly.
JAMA quietly polices who counts as a legitimate medical voice. Physicians inside academic and institutional medicine get amplified. Outsiders, renegades, or heterodox practitioners get sidelined.
This is classic guild behavior.
It also explains JAMA’s skepticism toward alternative medicine, direct-to-consumer health movements, and decentralized care models. These threaten professional monopoly.
During crises, JAMA tightens fast. Messaging becomes unified. Uncertainty is downplayed. Dissent is filtered.
Alliance Theory predicts this exact pattern. When stakes are high, coordination beats epistemic humility.
Despite criticism, JAMA is indispensable. Without it, American medicine would fragment into regional practices, ideological camps, and legal chaos.
JAMA persists because it does a job no one wants to name. It tells doctors what they are allowed to believe together.
JAMA is not where medicine goes to explore possibilities. It is where medicine goes to lock in authority.
A JAMA paper does not mean something is true in the deepest sense. It means the American medical alliance has decided this is the position it can safely defend, regulate, insure, teach, and litigate around.
That is real power.
I’ll treat Journal of the American Medical Association as an epistemic institution whose main function is managing the tacit dimensions of medical authority, not just publishing results.
Turner’s core insight
Stephen Turner’s central claim is that expertise is not primarily propositional knowledge. It is not a list of facts, methods, or rules that can be written down and transmitted cleanly. Expertise lives in tacit judgment, social trust, apprenticeship, institutional endorsement, and boundary policing.
Experts are experts because institutions agree to treat them as such.
From this angle, journals like JAMA are not truth engines. They are credentialing devices that stabilize who counts as an expert and what counts as legitimate judgment.
JAMA as a tacit coordination machine
JAMA’s real output is not information. It is closure around contested medical judgments that cannot be fully justified by data alone.
Clinical medicine is saturated with tacit decisions.
How much risk is acceptable.
Which uncertainty can be ignored.
When evidence is “good enough.”
What tradeoffs are morally tolerable.
These are not answerable by randomized trials alone. They require collective judgment.
JAMA exists to make those judgments appear settled.
Turner would say JAMA converts messy tacit expertise into written artifacts that stand in for judgment. Guidelines. Consensus statements. Authoritative reviews. Framed editorials.
Once written, these artifacts allow institutions to act as if the tacit problem has been solved.
Peer review as gatekeeping of judgment, not truth
From a Turner perspective, JAMA peer review is not about verifying facts. It is about asking a deeper question.
Can this claim be safely absorbed into the existing structure of medical expertise?
Reviewers are not checking equations. They are checking whether endorsing this position would destabilize tacit professional norms.
Would this force doctors to explain too much?
Would it undermine shared clinical instincts?
Would it expose judgment calls that are better left implicit?
JAMA disproportionately rejects work that forces medicine to make its tacit assumptions explicit.
That is not conservatism in the political sense. It is institutional survival.
Why heterodox critics bounce off JAMA
Turner is very clear that outsiders misunderstand how expertise works. They think experts win arguments by evidence alone.
They do not.
Experts win by occupying positions of trusted judgment inside institutions.
When heterodox clinicians or data-driven critics challenge JAMA-backed positions, they often believe they are offering better evidence.
But what they are actually doing is attacking the tacit authority structure that allows medicine to function at scale.
JAMA’s resistance is not epistemic stubbornness. It is defense of an ecosystem where judgment must remain partially opaque to remain legitimate.
The 2021 racism controversy reinterpreted
Seen through Turner, the 2021 episode was not primarily about ideology.
It was about a failure to respect tacit norms governing who is allowed to speak authoritatively about medicine’s moral foundations.
The deputy editor treated racism as a legal or definitional issue. But within elite medical institutions, racism had already become a tacit moral background assumption.
By making it explicit in the wrong way, he violated an unspoken rule of expert comportment.
The response was not just moral signaling. It was a repair of damaged tacit order.
JAMA had to demonstrate that its internal judgment culture still aligned with the broader institutional consensus about moral expertise.
Why JAMA leans moral
Turner emphasizes that expertise survives only when lay audiences trust expert judgment without fully understanding it.
Medicine therefore must present itself as ethically restrained, self-policing, and values-driven.
JAMA’s moral editorials are not add-ons. They are load-bearing.
They reassure courts, regulators, patients, and policymakers that medical judgment is not arbitrary power.
This moral framing protects the tacit authority doctors exercise every day.
Pharma, ads, and tacit legitimacy
The pharmaceutical relationship looks corrupt if you imagine medicine as pure science.
It looks different if you see medicine as a judgment profession.
Drug trials do not tell doctors how to prescribe. They tell them what they are allowed to prescribe without losing legitimacy.
JAMA publication plus advertising creates a shared tacit understanding of normal practice.
Doctors are not persuaded by ads. They are reassured that prescribing aligns with institutional expectations.
That reassurance is what matters.
Turner’s bottom line applied to JAMA
JAMA is not where medicine discovers truth.
It is where medicine stabilizes judgment.
It protects the tacit foundations of expertise by deciding which uncertainties can be ignored, which debates must stay internal, and which positions are safe to defend publicly.
A JAMA article does not say “this is correct.”
It says “this judgment will not cost you your standing.”
That is why JAMA endures.
That is why it feels conservative.
That is why it provokes outsider rage.
It is not a failure of science.
It is how expertise actually works.
Below is a practical power map, not a masthead list. This reflects who actually shapes outcomes at Journal of the American Medical Association, who can kill papers, steer norms, and trigger institutional reactions.
Power here is informal, reputational, and procedural, not just titular.
Tier 1. Ultimate authority
Kirsten Bibbins-Domingo
Editor in Chief, JAMA and the JAMA Network
Top of the pyramid. Final say on editorial direction, political alignment, crisis response, and what kinds of expertise are treated as legitimate. Sets tone for risk tolerance, moral framing, and alliance signaling. Does not micromanage papers but controls the environment in which all decisions are made.
American Medical Association leadership
Indirect but decisive power. They do not choose papers, but they define the red lines. Budget, institutional survival, advertiser tolerance, and political posture all flow upward to the AMA. When push comes to shove, JAMA aligns with AMA interests.
Tier 2. Operational gatekeepers
Phil B. Fontanarosa
Executive Editor
Arguably the most important internal actor day to day. Controls peer review pipelines, adjudicates reviewer conflicts, manages what escalates to the EIC, and quietly shapes what kinds of work ever reach decision stage. If Bibbins-Domingo sets strategy, Fontanarosa enforces it.
Senior Deputy Editors (collectively)
Names matter less than roles here. These editors oversee major content lanes such as clinical trials, health policy, public health, and guidelines. They decide what gets serious consideration and what dies early. They are deeply conservative and risk-focused.
Real power comes from longevity, not public visibility.
Tier 3. Agenda setters
Statistical Editors
Rarely named publicly, but extremely powerful. If a statistical editor flags a paper as methodologically fragile, it is usually over. They act as technocratic veto players and provide epistemic cover for rejecting inconvenient findings.
Guidelines and Consensus Editors
Editors who liaise with guideline committees and specialty societies. They shape which clinical positions become “standard of care.” Their influence extends far beyond the journal into hospitals, insurers, and malpractice norms.
Tier 4. Moral and political signaling nodes
Health Equity and Ethics Editors
Created or empowered post-2021. Their formal power is limited, but their veto power via reputational risk is substantial. They influence framing, language, and whether something is publishable in the current moral climate.
They rarely kill papers directly. They make papers dangerous.
Tier 5. External but critical power holders
High-status peer reviewers
Elite academic physicians at top US institutions. Individually replaceable, collectively decisive. Their judgments shape editor confidence. Editors lean heavily on reviewers who understand institutional risk, not just science.
Guideline committee chairs and specialty society leaders
Not on staff, but deeply entangled. JAMA rarely wants to be out of sync with them. Publishing against their consensus raises coordination and liability costs.
Former power center worth noting
Howard Bauchner
Former Editor in Chief
No longer influential, but his removal remains a cautionary tale inside the institution. Editors learned exactly where the moral and political boundaries lie.
How power actually works
JAMA is not run by one person issuing commands. It is run by overlapping veto points optimized to avoid institutional embarrassment, legal exposure, and alliance fracture.
The most powerful people are not the loudest. They are the ones who decide which judgments remain tacit and which must never be forced into the open.
1. Who dominates which subject domains inside Journal of the American Medical Association
This is informal power, not job titles.
Clinical trials and therapeutics
Controlled by long-tenured deputy editors and statistical editors. Priority is large US-relevant trials, pragmatic endpoints, and defensibility in malpractice settings. Mechanistic novelty is discounted. If a result cannot be cleanly translated into “reasonable physician behavior,” it stalls.
Guidelines and standards of care
Dominated by editors with deep ties to specialty societies and federal advisory bodies. These editors think downstream. How hospitals will operationalize. How insurers will reimburse. How courts will interpret. This lane has the highest external impact and the highest internal caution.
Health policy and systems
Run by editors aligned with federal agencies, large health systems, and payer logic. Preference for incremental reform, administrative feasibility, and moral framing over adversarial critique. Radical cost or scope challenges die quietly.
Public health and population studies
Strong influence from epidemiology and health equity editors. Observational work is acceptable if conclusions align with prevailing policy narratives. Methodological caveats are tolerated if the moral signal is correct.
Ethics, equity, and social medicine
Low formal rank, high reputational leverage. These editors shape language and framing across other domains. They do not decide what is true. They decide what is publishable without institutional blowback.
2. How a paper actually dies inside JAMA
Almost no papers die with a dramatic rejection.
Stage one: editorial triage
Most submissions die here. The question is not quality. It is institutional fit. Does this force medicine to surface uncomfortable tacit judgments. Does it complicate standard practice. If yes, it never enters full review.
Stage two: reviewer selection
Editors choose reviewers who understand institutional risk. A skeptical reviewer with the right prestige can end a paper with one paragraph. Editors lean heavily on “this would be hard to defend” comments.
Stage three: statistical soft veto
A flagged modeling choice, subgroup analysis, or data limitation becomes the official reason for rejection. This provides a neutral explanation even when the real issue is downstream impact.
Stage four: endless revision
Some papers are not rejected. They are exhausted. Requests for reframing, narrowing claims, removing implications, and softening language continue until the authors withdraw or the paper becomes harmless.
Stage five: silent freeze
The most sensitive papers are neither accepted nor rejected. They sit. Time kills them. No confrontation. No record.
Editors almost never say “this threatens the profession.” They say “this needs more work.”
3. How this differs from New England Journal of Medicine and The Lancet
JAMA
A coordination journal. Optimizes for US clinical governability. Oriented toward hospitals, insurers, boards, and courts. Its core function is stabilizing physician authority in a fragmented legal and political environment.
NEJM
An aristocratic legitimacy journal. Less policy-explicit. More confidence in its own judgment. Publishes fewer moral editorials because it assumes authority rather than defending it. More tolerant of bold claims if they come from the right institutions.
The Lancet
A political-moral journal with global ambitions. Willing to publish work that openly challenges governments, systems, and professions. Accepts higher controversy costs because its alliance is transnational and activist rather than guild-protective.
Put simply
NEJM says “trust us.”
JAMA says “this is safe.”
The Lancet says “this is a moral demand.”
JAMA is the most procedurally cautious of the three because it sits closest to liability, licensing, reimbursement, and domestic politics.
It is not built to discover uncomfortable truths quickly. It is built to ensure that when medicine moves, it moves together and can defend itself afterward.
